Education
About Us
Working with TipRanks
Follow Us
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
Total Valuation
China SXT Pharmaceuticals has a market cap or net worth of $2.44M. The enterprise value is -$17.72M.
Market Cap$2.44M
Enterprise Value-$17.72M
Share Statistics
China SXT Pharmaceuticals has 957,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding957,960
Owned by Insiders―
Owned by Institutions0.03%
Financial Efficiency
China SXT Pharmaceuticals’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -16.32%.
Return on Equity (ROE)-0.21
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-16.32%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee23.21K
Profits Per Employee-44.05K
Employee Count75
Asset Turnover0.08
Inventory Turnover1.66
Valuation Ratios
The current PE Ratio of China SXT Pharmaceuticals is ―. China SXT Pharmaceuticals’s PEG ratio is -0.35.
PE Ratio―
PS Ratio86.83
PB Ratio9.79
Price to Fair Value9.79
Price to FCF-64.40
Price to Operating Cash Flow-3.85
PEG Ratio-0.35
Income Statement
In the last 12 months, China SXT Pharmaceuticals had revenue of 1.74M and earned -3.30M in profits. Earnings per share was -8.18.
Revenue1.74M
Gross Profit367.43K
Operating Income-2.68M
Pretax Income-3.30M
Net Income-3.30M
EBITDA-2.57M
Earnings Per Share (EPS)-8.18
Cash Flow
In the last 12 months, operating cash flow was -2.35M and capital expenditures -2.02K, giving a free cash flow of -2.35M billion.
Operating Cash Flow-2.35M
Free Cash Flow-2.35M
Free Cash Flow per Share-2.45
Dividends & Yields
China SXT Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change-99.46%
50-Day Moving Average127.17
200-Day Moving Average214.59
Relative Strength Index (RSI)24.07
Average Volume (3m)289.38K
Important Dates
China SXT Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
China SXT Pharmaceuticals as a current ratio of 3.54, with Debt / Equity ratio of 5.95%
Current Ratio3.54
Quick Ratio3.40
Debt to Market Cap<0.01
Net Debt to EBITDA6.65
Interest Coverage Ratio-4.14
Taxes
In the past 12 months, China SXT Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
China SXT Pharmaceuticals EV to EBITDA ratio is -52.10, with an EV/FCF ratio of -57.11.
EV to Sales77.00
EV to EBITDA-52.10
EV to Free Cash Flow-57.11
EV to Operating Cash Flow-57.16
Balance Sheet
China SXT Pharmaceuticals has $18.10M in cash and marketable securities with $983.88K in debt, giving a net cash position of $17.12M billion.
Cash & Marketable Securities$18.10M
Total Debt$983.88K
Net Cash$17.12M
Net Cash Per Share$17.87
Tangible Book Value Per Share$38.20
Margins
Gross margin is 22.63%, with operating margin of -153.97%, and net profit margin of -189.77%.
Gross Margin22.63%
Operating Margin-153.97%
Pretax Margin-189.77%
Net Profit Margin-189.77%
EBITDA Margin-147.80%
EBIT Margin-152.53%
Analyst Forecast
The average price target for China SXT Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―